Gene · 7939
NIH grants1,570
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,570
Download this page as JSON| Grant | Title | LAP papers | Newest fiscal year |
|---|---|---|---|
| P30CA023100 | Specialized Cancer Center Support Grant | 1 | 2024 |
| P30ES000002 | Harvard Chan School NIEHS Center for Environmental Health | 1 | 2024 |
| P30EY002162 | P30 - Core Grant for Vision Research | 1 | 2024 |
| P41GM108569 | National Resource for Translational and Developmental Proteomics | 1 | 2024 |
| P41GM135019 | Center for Open Bioimage Analysis | 1 | 2024 |
| P50CA070907 | Targeting Lung Cancer Vulnerabilities | 1 | 2024 |
| P50CA098131 | SPORE in Breast Cancer | 1 | 2024 |
| R01AA022460 | Prenatal Alcohol and Neuroimmunity | 1 | 2024 |
| R01AA028043 | Alcohol and intestinal microvascular endothelium-immune axis and the role of gut derived immune nutrients | 1 | 2024 |
| R01AA028924 | Microglia Activation and TLR-induced Neurodegeneration by Alcohol Promotes Progression of Alzheimer Pathology | 1 | 2024 |
| R01AG018859 | Aging, Macrophage Mediators, and Burn Trauma | 1 | 2024 |
| R01AG067457 | Role of Peripheral Immune Cells in Cognitive Aging: The Framingham Offspring Study | 1 | 2024 |
| R01AI151707 | Heterogeneity of T cell phenotype and function in food allergy | 1 | 2024 |
| R01CA241927 | Tissue-Engineered Models of Glioblastoma for Evaluating Treatment Response | 1 | 2024 |
| R01CA244281 | Elucidating the Role of UCHL1 in Aggressive Prostate Cancer | 1 | 2024 |
| R01CA244550 | Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis | 1 | 2024 |
| R01CA251443 | Engineered microtumor arrays for development of combination therapies | 1 | 2024 |
| R01DA050528 | Targeting Inflammasomes in Substance Abuse and HIV | 1 | 2024 |
| R01DE028614 | Intraoperative bioprinting of composite tissues with zonal stratification for craniomaxillofacial reconstruction | 1 | 2024 |
| R01DK060540 | The Melanocortin-4 Receptor in Human Obesity | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7939/grants?page=17